SCM
BNTX icon

Silverarc Capital Management’s BioNTech BNTX Stock Holding History

Silverarc Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,083
Closed -$3.1M – 69
2024
Q3 		$3.1M Buy
+26,083
New +$2.4M 0.7% 40

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Silverarc Capital Management's BNTX Position: Q4 2024 in Review

Silverarc Capital Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 26,083 shares — an estimated $3.1M sold.

Silverarc Capital Management first reported a position in BNTX in Q3 2024 and held it in 1 quarter. The position peaked at $3.1M in Q3 2024. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Silverarc Capital Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Silverarc Capital Management sold 26,083 BioNTech shares in Q4 2024, an estimated $3.1M.
  • Silverarc Capital Management first reported a position in BioNTech in Q3 2024 and held it in 1 quarter.
  • Silverarc Capital Management's BioNTech position peaked at $3.1M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Silverarc Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.